 |
A
call for sponsorship to support the running and future development
of Glycosmedia |
| |
Click on the above headline for an overview
of the Glycosmedia diabetes news service and our call for sponsorship.
Brief details on how sponsorship will work can be seen here. For further details please contact (Jim Young, Editor-in-Chief) |
| |
|
|
BT
helps its 8,000 people with diabetes to tackle growing problem
for businesses |
| |
BT today launched a campaign to try to help
thousands of its people avoid developing Type 2 diabetes or manage
it better if already diagnosed – by changing their lifestyle (BT, UK) |
| |
|
|
Systematic
review: Cardiovascular outcomes in trials of oral diabetes medications |
| |
The authors note that clinical trials of oral
therapies for type 2 diabetes mellitus have largely focused on
intermediate clinical outcomes, such as changes in HbA1c, serum
lipids and blood pressure. Specific effects CV risks remain unclear
but such outcomes have ‘unequivocal clinical relevance’(National electronic Library for Medicines) |
| |
|
|
Beyond
Glycemic Control: Managing Obesity and Cardiovascular Disease
Risk for Patients With Type 2 Diabetes in the Primary Care Setting |
| |
With increasingly more individuals affected
by diabetes, it is important for primary care clinicians to understand
and effectively manage the comorbid conditions associated with
this disease (PeerView inSight) |
| |
|
|
Expensive
new diabetes drugs may not be worth the money |
| |
The annual cost of diabetes drugs in the USA
have nearly doubled to $12.5 billion between 2001 and 2007, raising
questions about whether this actually translates into improved
care (PharmaTimes) |
| |
|
|
The
Handbook for Vascular Risk Assessment, Risk Reduction and Risk
Management |
| |
This handbook brings together in one place information
on our current state of knowledge about vascular risk assessment,
risk reduction and risk management. It has been designed to be
comprehensive, giving an overview of the latest state of knowledge.
150-page PDF (National Screening Committee) |
| |
|
|
Sources
of funding |
| |
If you know of any sources of funding that we
can contact to support the running and future development of Glycosmedia
then please mail Jim Young, Editor-in-Chief jim@glycosmedia.com |
| |
|
